HCA Healthcare Inc (NYSE: HCA) has reported E.P.S. of $4.88 for its third fiscal quarter (ending September 30) versus $3.98 for the same period a year ago — an increase of 23%. For the latest four quarters through September 30, E.P.S. were $22.39 versus $20.68 for the same period a year ago — an increase of 8%.
Recent Price Action
HCA Healthcare Inc (NYSE: HCA) stock suffered a large decline of -8.9% on 10/25/24. The stock closed at $363.55. Moreover, this decline was accompanied by exceptionally high trading volume at 359% of normal. The stock has been exceptionally strong relative to the market over the last nine months but has declined -10.6% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, HCA is expected to be an important Value Eraser.
HCA Healthcare is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment